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The development of an effective malaria vaccine has been hampered by the genetic diversity of commonly
used target antigens. This diversity has led to concerns about allele-specific immunity limiting the effective-
ness of vaccines. Despite extensive genetic diversity of circumsporozoite protein (CS), the most successful
malaria vaccine is RTS/S, a monovalent CS vaccine. By use of massively parallel pyrosequencing, we evaluated
the diversity of CS haplotypes across the T-cell epitopes in parasites from Lilongwe, Malawi. We identified 57
unique parasite haplotypes from 100 participants. By use of ecological and molecular indexes of diversity, we
saw no difference in the diversity of CS haplotypes between adults and children. We saw evidence of weak
variant-specific selection within this region of CS, suggesting naturally acquired immunity does induce
variant-specific selection on CS. Therefore, the impact of CS vaccines on variant frequencies with widespread
implementation of vaccination requires further study.
Although the estimated annual numbers of malaria in-
fections (approximately 225 million) and deaths
(approximately 781 000) remain high, recent successes
in reducing transmission have triggered discussions
about global malaria elimination [1–3]. However, our
current tools are unlikely to achieve this goal. An ef-
fective Plasmodium falciparum vaccine would add an
important tool to our armamentarium.
A major challenge to developing a broadly useful
malaria vaccine has been the diversity of the falcipa-
rum parasite population [4]. P. falciparum is a highly
genetically diverse organism with potentially hundreds
of unique genotypes at key loci circulating within a
population and infections commonly containing mul-
tiple variants [5]. Recent studies have shown that one
potential vaccine target, apical membrane antigen-1,
may have >200 haplotypes within a single town in
Mali, and this diversity has caused a candidate vaccine
to be broadly ineffective [6, 7].
To date, the most successful malaria vaccine has been
RTS,S. RTS,S AS01E is a monovalent circumsporozoite
protein (CS) malaria vaccine undergoing a phase III
trial in 7 countries at 11 sites. Initial data from this trial
has shown an estimated efficacy of 55% [8]. The molec-
ular biology of CS and the development of RTS,S have
recently been reviewed [9, 10]. The antigen covers the
entire surface of sporozoites and is coded for by a
single-copy gene (csp). The structure of CS is immuno-
logically dominated by a central tandem amino acid
repeat and a series of T-cell epitopes in the carboxy ter-
minal of the molecule (Figure 1A). The primary T-cell
epitopes, TH2 and TH3, are known to be highly
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polymorphic in natural parasite populations [11–15]. This diver-
sity may in part explain why RTS,S is only partially effective.
It is still unclear what mechanisms are responsible for
maintaining polymorphisms in the TH2 and TH3 epitopes of
CS. Good et al suggested that they were maintained by natural
selection favoring immune evasion (allele-specific immunity)
[12]. This hypothesis was supported by the observation that
the number of nonsynonymous nucleotide substitutions was
higher than the number of synonymous nucleotide substitu-
tions in some populations [16, 17]. On the other hand, recent
evidence suggests that among CS isolates in the Gambia, there
is only limited evidence of balancing selection, implying
minimal allele-specific immunity in CS [18]. Whether there is
allele-specific immunity generated against CS is critical to pre-
dicting the long-term usefulness of a monovalent CS vaccine.
To understand the diversity of csp within the falciparum
parasite population in Lilongwe, Malawi, we conducted an
observational study in 2010 involving 100 parasitemic
participants. A region spanning the TH2 and TH3 epitopes of
csp was amplified from each participant in duplicate and ultra-
deep sequenced, using massively parallel pyrosequencing
(MPP). To our knowledge, this is the first population genetic
study of malaria diversity reported using MPP. By using the
sequence data, we identified the existing parasite haplotypes
(also termed “variants”) currently in the population and, for
the first time, their relative frequency within individuals. By
use of these metrics, we compared children and adults in terms
of haplotype diversity and richness, using several ecological
and molecular indexes. We then assessed the haplotypes for
evidence of selection on the TH2 and TH3 epitope region.
MATERIALS AND METHODS
Study Population
Informed consent as approved by the University of North
Carolina Institutional Review Board and Malawian National
Figure 1. TH2 and TH3 polymorphisms and haplotypes of csp variants. A, Schematic structure of CS (not to scale) with the locations of the NANP
repeat (blue), TH2 epitope (green), and TH3 epitope (yellow) highlighted. The signal peptide and anchor sequences are also shown (red). The locations of
the primers are marked by the arrows. B, DNA alignment of all 57 unique variants detected in the population. Nucleotides are represented by different
colors (adenine, red; thymine, blue; cytosine, green; and guanine, yellow). The position of the TH2 and TH3 epitopes are marked. C, Amino acid alignment
of all 57 unique variants detected in the population. Amino acids are represented by different colors (alanine, brick red; arginine, yellow ochre; aspara-
gine, violet; aspartic acid, orange yellow; cysteine, forest green; glutamic acid, blue; glutamine, medium blue; glycine, dirty yellow; histidine, bright red;
isoleucine, red; leucine, dark purple; lysine, pink; methionine, magenta; proline, indigo; serine, light blue; threonine, bright blue; tryptophan, medium
green; tyrosine, parrot green; and valine, light green; phenylalanine is not seen). The position of the TH2 and TH3 epitopes are marked.
csp T-Cell Epitope Diversity • JID 2012:206 (15 August) • 581
Health Sciences Research Committee was received from all
study participants in this observational study. One hundred
participants were enrolled at the outpatient clinics at Kamuzu
Central Hospital in Lilongwe, Malawi, between March and
June 2010. In total, 50 adults (age range, 19–61 years; mean
age [±SD], 30 ± 10 years) who presented to the clinic with
symptoms consistent with uncomplicated malaria were en-
rolled sequentially. In addition, 50 children (age range, 1–5
years; mean age [±SD], 3 ± 0.7 years) were enrolled in parallel.
There was no difference in sex distribution between adults and
children. Children <5 years of age routinely have malaria
smears done in the clinic as part of the vast majority of evalu-
ations, so some children may have been asymptomatic at the
time of enrollment. All smears were reviewed by 2 microsco-
pists, and patients who were smear positive for falciparum
malaria with a parasitemia of ≥2+ (discussed in the Supple-
mentary Materials) were approached about participation in
the study. Any person with signs of severe malaria was exclud-
ed from the study. Dried blood spots were collected and
stored in individual packets with desiccant at room tempera-
ture until shipment.
Amplification and Sequencing of csp
The region of csp containing the TH2 and TH3 epitopes was
amplified from extracted DNA by use of previously described
primers [19], which we modified for 454 sequencing by inclu-
sion of a linker, tag, and a multiplex identifier (MID) se-
quence. Each patient sample was amplified in duplicate, using
unique MIDs. Amplicons were pooled and sequenced on a
454 Life Sciences sequencer, using the Titanium chemistry at
the University of North Carolina High Throughput Sequenc-
ing Facility. Further details are provided in the Supplementary
Materials.
Haplotype Determination From MPP
Haplotypes of csp variants were determined using a combina-
tion of Bayesian and heuristic clustering that is detailed in the
Supplementary Materials. In brief, sequence reads were sepa-
rated on the basis of MIDs from the pooled data into ampli-
con-specific data, resulting in 2 independent amplicon data
sets for each participant. The sequences were trimmed of
MIDs, tags, and primers and were culled of low-quality reads
on the basis of previously determined cutoffs for given charac-
teristics (eg, length and quality scores). These resultant high-
quality read sets were further clustered by ShoRAH to predict
the most likely haplotypes within the patient [20]. The Baye-
sian model in this program provides a posterior probability
that the predicted haplotype is a true haplotype. This was used
to remove unlikely low-frequency haplotypes from further
analysis.
ShoRAH is limited in that it models a uniform error rate
across the sequence. This potentially leads to spurious
haplotypes because of increased differences called within the
error prone 3′ sequence. To correct for this, we employed a
second heuristic clustering step to further collapse the com-
bined ShoRAH haplotypes from both amplicons that differed
by no more than 1 substitution but up to 5 small (1 or 2
bases) indels and to predict, by consensi, the likely true haplo-
types for each participant. As each sample was amplified in
duplicate and sequenced independently, we required that the
final haplotypes from a participant be composed of only
haplotypes identified from both independent amplicons and
represent ≥1% of the total reads for a participant. By requiring
the haplotype to occur independently in 2 polymerase chain
reaction (PCR) assays, we limit the potential for false haplo-
types due to PCR or sequencing error. To examine haplotypes
at the population level, a similar clustering (allowing for only
small indels) and consensus determination was performed as
described above across the combined haplotypes from all indi-
viduals. The resulting weighted consensi provided the final
haplotypes for analysis and was assigned a unique population
identifier (pUID).
Data Analysis
DNA alignments and figures were generated using MegAlign
and GeneVison software (DNAStar, Madison, WI). Ecological
indexes of diversity and rarefaction curves were determined
using EstimateS v8.2 [21]. Calculations of molecular diversity
and evolution were done using Arlequin v3.5.1.2 and DnaSP
v5.0 [22, 23]. The median-joining network was created using
DNA Alignment v1.2.1.1 and Network v4.6.0.0 [24]. For this
analysis, a multiplicity of infection (MOI) is defined as the
number of unique CS haplotypes in an individual infection.
Additional information about data analysis and MOI is pro-
vided in the Supplementary Materials.
RESULTS
Determination of Unique Haplotypes
The number of sequence reads passing the initial quality filter
was 1 605 260. A total of 1 562 833 sequences (97.3%) are rep-
resented in the final data after construction of the unique
variant consensus haplotypes. The average number of reads
used to construct haplotypes in each patient was 15 682 (SD =
5301). Therefore, the majority of haplotypes at our lower
limit, representing 1% of the parasite population within a
patient, used a minimum of 100–200 sequencing reads to con-
struct sequence of the haplotype. The final sequence length of
all variants was 265 base pairs because of trimming of bases
during haplotype building.
In total, 57 unique parasite haplotypes based upon DNA
sequence spanning TH2 and TH3 were detected in the
population (GenBank accession no. JN634586-JN634642)
(Figure 1B). These variants represented frequencies of ≥1%
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within the individual participants and were supported by both
independent amplifications for the given participant. Their
frequencies within the entire population ranged from 0.01% to
12% and occurred in 1–25 samples. Population frequencies
are estimated by the sum of the fractional representation
across individuals and are not corrected for parasitemia
because quantitative microscopy reads were not available. Am-
plicon sequencing by MPP has been used to determine fre-
quencies of variants from clinical samples for other organisms
[25]. However, it is possible that frequency estimates may be
biased during PCR amplification, affecting any frequency-
based estimates of diversity. Biases have been associated with
variability in amplicon length, differences underlying the PCR
primers, and extensive PCR cycles. This potential bias should
be minimal in this study because the fragment is of uniform
length with well-conserved primer regions and was amplified
using a modest number of PCR cycles.
These 57 haplotypes also represented 57 unique amino acid
sequences (Figure 1C). In total, 30 unique TH2 epitopes and
15 unique TH3 epitopes were identified. Among these, only 3
haplotypes (9%) and 1 haplotype (5%) carried the sample
TH2 and TH3 epitopes, respectively, as falciparum strain 3d7
(the RTS,S strain). Only 1 variant contained the same TH2
and TH3 epitope haplotype as falciparum strain 3d7. This
haplotype represented only 5% of the sequences from the
population.
MOI and Ecological Indexes of Haplotype Diversity
Although several samples were highly complex (6 samples had
a MOI of ≥5 variants), in general the average MOI was low
(Table 1). The average MOI for the entire population was 2.31
(SD = 1.70) variants/infection (range, 1–12 variants/infection).
Children and adults had similar MOIs (P = .7288, by the un-
paired 2-tailed t test). There was no difference in mean MOI
(SD) on the basis of parasitemia (2.5 [1.8], 2.4 [1.9], and 2
[1.2] in the 2 + , 3 + , and 4 + groups, respectively).
Species richness, or the number of species in a sample of a
specified size, is an easily comprehensible expression of
species “diversity.” To determine whether there were signifi-
cant differences in species (or, in this case, haplotype) richness
among the Lilongwe parasite population, we used EstimateS to
evaluate 7 nonparametric estimators of species richness
(Chao1, Chao2, incidence-based coverage estimator, abun-
dance-based coverage estimator, Jack1, Jack2, and Michaelis-
Menten mean) [21]. We looked at the total diversity of the
sample, as well as the diversity of parasites within adults and
within children. No differences in species richness were seen
between any of these groups for any of these indexes. The
Chao2 provides a 95% confidence interval for its estimate of
species richness and gives an easily interpretable estimate of
the expected richness in the population (Table 1) [26].
By use of EstimateS, we also calculated indexes of species
diversity. Unlike indexes of species richness, indexes of species
diversity combine information on species richness (ie number
of variants) and species abundance (ie frequency of variants)
in different ways. Again, no differences in species diversity
were seen between these populations, using Shannon, Expo-
nential Shannon, Alpha, and Simpsons Indexes.
Haplotype Discovery
In general, the number of entities discovered is highly depen-
dent on sampling effort. In the current context, this means
that, as more sequences are analyzed, the number of variants
discovered will increase. This is evident in our sample
(Figure 2). The variant accumulation curve of our plotted data
does not yet appear to be reaching its asymptote, suggesting
that further sampling may result in the identification of addi-
tional haplotypes. This data was used to develop smoothed
rarefaction curves for our population, which estimate the
number of haplotypes that would be detected at any given
sampling level. Figure 2A shows the rarefaction curve and raw
data for the entire population. Figure 2B and 2C show the rar-
efaction curves for the adults and children, respectively. The
curves for the 2 populations are similar, and neither reaches
its asymptote.
Median-Joining Network
A median-joining network was developed for the csp haplo-
types (Figure 3). Similar approaches have been used previously
in malaria research [27]. Figure 3 suggests that csp variants in
Lilongwe are clustered into 3 major groups. All variants
sharing the 3d7 TH2 epitope clustered in the arm of the
Table 1. Multiplicity of Infection (MOI) and Indexes of Haplotype Diversity
Variable Total Population Adults Children
MOI
Mean (SD) 2.31 (1.70) 2.28 (1.81) 2.34 (1.61)
Median 2 2 2
Chao2, mean (95% CI) 77.34 (64.45–112.52) 90 (58.31–183.23) 65.34 (52.45–100.52)
Exponential Shannon, mean 25.07 22.58 23.26
θ(π) 0.02 0.02 0.02
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Figure 3. Median-joining network of csp variants. The network was developed using the complete 265–base pair sequence for each haplotype.
These networks allow for a visual representation of the mutational paths that may have led to the observed data and assume that mutations are more
likely to derive from a more frequent haplotype and proceed to a less frequent haplotype [27]. Parasite variants are shown in the black circles. The size
of the circle is relative to the frequency of the variant in the population. Variant pUID8 (dark grey circle) shared the same 265–base pair sequence as
strain 3d7 (labeled 3d7 in the figure). Median vectors are shown in light grey circles. Median vectors represent hypothetical ancestral haplotypes linking
existent haplotypes or may represent haplotypes not sampled. The length of links is not proportional to the number of mutational steps separating
haplotypes.
Figure 2. Accumulation and rarefaction curves of csp variants. A, Variant accumulation and rarefaction curves for the entire population. The thick
solid line shows the raw data for the variant accumulation curve. The computed rarefaction curve (thin solid line) represents the expected average rate
of variant accumulation that would be produced by repeated deep sequencing of the same population. Confidence intervals (CIs) for the species richness
were also determined (dashed and dotted lines represent upper and lower 95% CIs, respectively). CIs for rarefaction curves allow for the comparison of
diversity between populations, even when there are differences in sampling effort. B and C, Rarefaction curve (thin solid line) and 95% CIs (dotted
lines) for the adult (B) and child (C) populations.
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network that contained 3d7 (including the 2 variants that
shared TH2 and TH3). The variant that contained the same
TH3 as 3d7, but a highly different TH2, clustered away from
this arm (pUID10). Similar to previous reports, associations
between the common haplotypes show that the TH2 and TH3
epitope sequences do not randomly assort and that the combi-
nations that exist within a single CS molecule may be con-
strained (data not shown) [13].
Sequence Polymorphisms and Molecular Evolution
In addition to the ecological evidence that there is not a diffe-
rence in diversity between groups, our molecular evaluation
supports this finding. With DNA sequences, diversity is de-
scribed by variation in the nucleotide sequences among the
parasites, since all the samples sequences are related through
common ancestry. The total genetic variation is referred to as
θ, and various statistics have been used to describe this diver-
sity [23, 28–31]. In the population of parasites sampled in our
study, several θ estimators (θHom, θπ, and θS) show no differ-
ences between the populations (Table 1) [23].
The overall genetic distance between parasite haplotypes
was evaluated. The haplotypes on average had a mean number
of pairwise differences (π) of 0.02 (Table 1). Differences of
>50 single-nucleotide polymorphisms (across the whole gene)
have been reported between some parasite variants. Individual
haplotypic distance matrices for both adults and children are
presented in Supplementary Figure 1, suggesting a uniform
distribution of differences among the population. In total,
there were 24 polymorphic loci within the 265–base pair
fragment analyzed. The allele frequencies for these loci are
presented in Supplementary Table 1, and the expected hetero-
zygosity for these loci is shown in Supplementary Figure 1.
On a population level, there was not a significant distance
between parasites found in adults and children (population
pairwise F statistic = 0.00022). This is lower than previously
reported F statistic values from the Gambia for csp [18].
Interestingly, all 24 detected differences were nonsynon-
ymous coding changes. This lack of synonymous changes sug-
gests that our haplotypes contain minimal error, since we
would expect that base changes would occur without diffe-
rence to the coding potential, and thus we would expect ap-
proximately 1 of 3 errors to occur within a synonymous site.
Evidence of Selection on the C-terminus of CS
This study also showed some evolutionary selective pressure
on csp within the parasite population sampled. Although all
observed differences were nonsynonymous, nucleotide substi-
tutions across the entire amplified region failed to show signif-
icant departures from neutrality (Figure 4). However, the
regions containing TH2 and TH3 had weakly positive indexes
for all 3 tests, suggesting an excess of intermediate-frequency
alleles in a population. This is similar to previous reports in
the Gambia [18]. Because of the lack of synonymous polymor-
phisms, dN/dS ratios were unable to be calculated. Finally, by
use of a nonhierarchical island model to test for specific nucle-
otides under selection, we saw only 8 sites with evidence of
selection (P < .05) (Supplementary Figure 1). Interestingly, all
8 loci fall within the TH2 and TH3 epitopes.
DISCUSSION
The diversity of csp variants in Lilongwe, Malawi, was de-
scribed using MPP, a novel method for a malaria population
genetics study. This method is particularly useful in this
context because it allows one to gain insights into infections
that are polyclonal or contain minority variants (unlike Sanger
sequencing, which provides only information on the dominant
variant) and provides information on the frequency of each
variant within an infection in a high-throughput manner
[5, 20]. Multiple reports have applied MPP to the detection
and characterization of rare drug-resistant human immunode-
ficiency virus (HIV) variants and to address questions on the
dynamics of HIV quasispecies in response to selective pressure
[32–36]. Here we describe a method that is capable of detect-
ing variants that are ≥1% of the parasite population within an
individual. The ability to accurately and quantitatively describe
Figure 4. Tests of neutrality to evaluate for selection on csp. A,
Results for Tajima D and Fu and Li D* and F* statistics on the complete
sequences of csp. B, Results of the same tests as in A, using a sliding
window of 50–base pair size over the complete amplicon (slide of 15
base pairs). The y-axis is the statistical result for the index. The x-axis
represents the midpoint base pair of the window evaluated. Despite
peaks in the Tajima’s D around TH2 and TH3, no significant evidence of
selection is seen across this region (no value of the index >2). Fu and Li
D* and F* tests also showed a positive trend in these regions. The posi-
tive nature of these indexes suggests an excess of intermediate-
frequency alleles in a population and can result from either balancing
selection or population bottlenecks.
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the in-host population of malaria parasite variants is critical
for a more detailed understanding of the ecological interac-
tions that selective pressures, such as drugs or vaccines, place
on the parasite population.
By use of this method, we discovered 57 unique csp haplo-
types in Lilongwe. However, the data suggest that this is only a
portion of the actual number of circulating parasite haplo-
types. It is clear from the variant accumulation curve and rar-
efaction curve that continued sampling would likely find
additional haplotypes in the population. The extensive diver-
sity of csp has clearly led to a significant number of different
TH2 and TH3 alleles in the parasite population in Lilongwe.
However, the impact of this diversity on the effectiveness of
CS vaccines may be limited.
Tests for balancing selection were not significant across the
complete region of CS in our study. This supports previous
findings that showed no evidence of strong balancing selection
for the complete csp gene and reports showing common csp
alleles being maintained in an endemic Thai population for
several years without declining in frequency [18, 37]. However,
our study, along with previous studies, have shown peaks in
Fu and Li D*, Fu and Li F*, and Tajima’s D indexes around
TH2 and TH3, suggesting an excess of intermediate-frequency
alleles in a population [18]. This suggests that diversity at
these regions is likely beneficial to parasite survival and that
weak allele specific selective pressure, likely from naturally ac-
quired immunity, does occur in these regions.
In this study, we saw no difference in the MOI between
adults and children. We also saw no differences in the diver-
sity of parasites between adults or children, using several eco-
logical and molecular indexes of richness and diversity.
However, we detected an extreme number of nonsynonymous
polymorphisms, weak evidence of balancing selection at TH2
and TH3, and a high level of diversity consistent with previous
African studies [38]. Given that this level of nonsynonymous
substitution and diversity is far from the norm for the falcipa-
rum genome, this suggests that the selection may be a mixture
of both balancing and directional selection, similar to the
HLA loci [39], and only underscores the complexity of
the region. Such mixed forces could maintain diversity over
the long term while keeping certain alleles at higher frequency
on the basis of inherently increased virulence. While this
high-level of diversity in the T-cell epitopes suggests func-
tional interplay with the human host immune system, it is not
inconsistent with the hypothesis suggesting that this region
may be under selective pressure in the mosquito host [37].
Variant replacement is a treatment-induced phenomenon
in which vaccination drives the emergence and dominance of
once-rare pathogen variants [40, 41]. This occurs because of a
destabilization of the existing host-pathogen evolutionary
equilibria or because of an acceleration of pathogen evolution
[40, 41]. The standard explanation for treatment-induced
pathogen variant replacement rests on the frequent observa-
tion that different strains respond differently to treatment
(differential effectiveness) [40, 41]. However, some evidence
suggests that vaccine-induced strain selection can also occur
even in the case where a vaccine is equally effective against
variants [40, 42]. The lack of a strong variant-specific effect by
naturally acquired immunity between age groups suggests that
strain selection by RTS/S may not occur quickly. To date, 3
studies have evaluated strain selection by RTS,S candidate vac-
cines by looking at the TH2 and TH3 epitopes [13, 15, 43].
None of these found evidence of selection occurring.
However, 2 of the 3 studies showed a decrease in the MOI in
vaccinated individuals. Unfortunately, these studies were
somewhat methodologically limited because they used geno-
typing techniques that do not determine true frequencies and
only detect the dominant strains in polyclonal infections. If
the selective pressure of immunity on csp is weak, it is likely
that the effects of selection or strain replacement may only be
manifested in subtle shifts of frequency initially. In addition,
these studies assessed time points shortly after initial vaccina-
tion and relatively small numbers of variants, and the time it
takes to manifest strain selection may be quite long and
require a larger population to detect. The observation of weak
evidence of selection on TH2 and TH3 in population studies,
as well as a decrease in MOI in several vaccine studies, sug-
gests that close monitoring of strain selection by RTS/S should
be conducted as more individuals receive the vaccine and
duration of follow-up is extended.
In this study, we report the first population genetic analysis
in malaria using MPP. This technique provides a powerful
tool for evaluating the ecological and evolutionary phenome-
non induced by selective pressures, such as drugs or vaccines,
on the parasite population. We saw extensive diversity in csp
among the parasites in Lilongwe, Malawi. However, the selec-
tive pressures put on csp by naturally acquired immunity
appear to be weak. This potentially bodes well for CS-based
vaccines in terms of longevity and breadth of use. However,
even weak levels of selection may lead to strain replacement,
which will need to be monitored as CS vaccines become more
widely used.
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